Cargando…
A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson's Disease
Parkinson's disease (PD) is an age-related neurodegenerative disorder characterized in part by the preferential loss of nigrostriatal dopaminergic neurons. Although the precise etiology of PD is unknown, accumulating evidence suggests that PD involves microglial activation that exerts neurotoxi...
Autores principales: | Chinta, Shankar J., Rajagopalan, Subramanian, Ganesan, Abirami, Andersen, Julie K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361310/ https://www.ncbi.nlm.nih.gov/pubmed/22666629 http://dx.doi.org/10.1155/2012/364684 |
Ejemplares similares
-
Isopropyl 3,4-dihydroxybenzoate
por: Shen, Xu-Ji, et al.
Publicado: (2011) -
Anilinium 3,4-dihydroxybenzoate
por: Zhu, Si-Ming
Publicado: (2012) -
Triethylammonium 3,4-dihydroxybenzoate
por: Zhu, Li-Cai
Publicado: (2010) -
A Prolyl-Hydroxylase Inhibitor, Ethyl-3,4-Dihydroxybenzoate, Induces Cell Autophagy and Apoptosis in Esophageal Squamous Cell Carcinoma Cells via Up-Regulation of BNIP3 and N-myc Downstream-Regulated Gene-1
por: Han, Bo, et al.
Publicado: (2014) -
3,4-Dihydroxybenzoic acid pyridine monosolvate
por: Zhu, Li-Cai
Publicado: (2010)